This inventor holds 2 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: University of Rochester. Active years: 2011-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011-2016
Title: William Bonnez: Innovator in Papillomavirus Research
Introduction
William Bonnez is a notable inventor based in Rochester, NY (US). He has made significant contributions to the field of virology, particularly in the development of methods and compositions for preventing viral infections. His work has led to the issuance of two patents that focus on papillomavirus and its implications for public health.
Latest Patents
Bonnez's latest patents include a formulation of papillomavirus virus-like particles (VLPs) or capsomeres that serve as microbicides. These compositions are designed to block papillomavirus binding receptors on the surface of cells, thereby preventing viral infections. His second patent details a method for expressing the papillomavirus capsid protein in cells, which facilitates the production of VLPs that exhibit antigenic characteristics similar to native infectious papillomavirus particles.
Career Highlights
William Bonnez has dedicated his career to researching viral infections and developing innovative solutions to combat them. His work at the University of Rochester has positioned him as a leading figure in the field of papillomavirus research. His inventions have the potential to significantly impact the prevention of viral infections.
Collaborations
Bonnez has collaborated with esteemed colleagues such as Robert C. Rose and Richard Reichman. These partnerships have enhanced the scope and impact of his research, contributing to advancements in the understanding of papillomavirus.
Conclusion
William Bonnez is a pioneering inventor whose work in papillomavirus research has led to valuable patents and innovative solutions for preventing viral infections. His contributions continue to shape the field and offer hope for improved public health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
